In-hospital costs of coronary stent implantation with and without eptifibatide (the ESPRIT Trial)
James E. Tcheng(Duke University), James Slater(NYU Langone Health), J.Conor O’Shea(Duke University), Ian J. Sarembock(Christ Hospital), Eric H. Conn(Memorial Hospital), Jack Smith(Saint Vincent Hospital), Glenn N. Levine(American College of Cardiology), Cindy M. Pacchiana(Clinical Research Institute)
Cited by 23
Related Papers
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
|Journal of the American College of Cardiology|2014|3.6k
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
|Circulation|2011|3.3k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
|Journal of the American College of Cardiology|2011|2.2k
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
|Journal of the American College of Cardiology|2016|1.6k